Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: فاطمه رنجبر , همایون صادقی بازرگانی , اصغر ارفعی , مصطفی فرح بخش

کلمات کلیدی: hyperprolactinemia, aripiprazole, risperidone, psychotic disorder

نشریه: 41882 , 11 , 2015 , 2015

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله فاطمه رنجبر
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه روانپزشکی و علوم رفتاری
کد مقاله 72592
عنوان فارسی مقاله Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
عنوان لاتین مقاله Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
ناشر 6
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Background: Antipsychotics have been used for more than 50 years in the treatment of schizophrenia and many other psychiatric disorders. Prolactin levels usually increase in patients treated with risperidone. Aripiprazole, which has a unique effect as an antipsychotic, is a D2 receptor partial agonist. It is an atypical antipsychotic with limited extrapyramidal symptoms. Since it acts as an antagonist in hyperdopaminergic conditions and as an agonist in hypodopamin- ergic conditions, it does not have adverse effects on serum prolactin levels. The present study aimed to investigate the effect of aripiprazole on risperidone-induced hyperprolactinemia. Methods: This before-and-after clinical trial was performed in 30 patients. Baseline prolactin levels were measured in all patients who were candidates for treatment with risperidone. In subjects with elevated serum prolactin, aripiprazole was added to their treatment. Serum prolactin levels were measured during the first week, second week, and monthly thereafter for at least 3 months or until prolactin levels became normal. The data were analyzed using Stata version 11 software. Survival analysis and McNemar’s test were also performed. Results: The mean age of the participants was 30.8 years. Prolactin levels normalized in 23 (77%) participants during the study, and menstrual disturbances normalized in 25 (83.3%). Prolactin levels normalized in most patients between days 50 and 110. The median time to recovery based on normalization of prolactin was 84 days. Psychotic symptoms were present in 26 subjects at baseline, but in only two by the end of the study. Conclusion: The results of this study confirm the effects of aripiprazole in reducing risperidoneinduced hyperprolactinemia and its sequelae. Aripiprazole also led to significant improvements in psychotic symptoms when compared with those present prior to treatment with aripiprazole.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
فاطمه رنجبراول
همایون صادقی بازرگانیدوم
اصغر ارفعیچهارم
مصطفی فرح بخشششم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
1.pdf1399/03/27742951دانلود